Structural bases of vasopressin/oxytocin receptor function

Journal of Endocrinology

Volumn 156, Issue 2, 1998, Pages 223-229

  Barberis, C ^a   Mouillac, B ^a   Durroux, T ^a  

^a CCIPE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CORTICOTROPIN; DIACYLGLYCEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; LIGAND; MESSENGER RNA; N ETHYLMALEIMIDE; OXYTOCIN; OXYTOCIN RECEPTOR; OXYTOCIN[2 PHENYLALANINE 8 ORNITHINE]; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; RECEPTOR SUBTYPE; RELCOVAPTAN; THIOL GROUP; THROMBOCYTE RECEPTOR; VASOPRESSIN; VASOPRESSIN RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; GLYCOSYLATION; HUMAN; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION;

EID: 0031951116     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1560223     Document Type: Review

References (50)

1. 2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. Journal of the American Society of Nephrology (In Press).
2. Barberis C & Tribollet E 1996 Vasopressin and oxytocin receptors in the central nervous system. Critical Reviews in Neurobiology 10 119-154.
3. Bichet D, Arthus M, Lonergan M, Hendy G, Paradis A, Fujiwara M, Morgan K, Gregory M, Rosenthal W, Didwania A, Antaramian A & Birnbaumer M 1993 X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. Journal of Clinical Investigation 92 1262-1268.
4. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P & Rosenthal W 1992 Molecular cloning of the receptor for human antidiuretic hormone. Nature 357 333-335.
5. Birnbaumer M, Gilbert S & Rosenthal W 1994 An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system. Molecular Endocrinology 8 886-894.
6. Briley E, Lolait S, Axelrod J & Felder C 1994 The cloned vasopressin V1a receptor stimulated phospholipase A2, phospholipase C and phospholipase D through activation of receptor-operated calcium channels. Neuropeptides 27 63-74.
7. Carnazzi E, Aumelas A, Barberis C, Guillon G & Seyer R 1994 A new series of photoactivatable and iodinatable linear vasopressin antagonists. Journal of Medicinal Chemistry 37 1841-1849.
8. Carnazzi E, Aumelas A, Phalipou S, Mouillac B, Guillon G, Barberis C & Seyer R 1997 Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist. European Journal of Biochemistry 247 906-913.
9. Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S & Barberis C 1995 Tyr 115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO Journal 14 2176-2182.
10. Chini B, Mouillac B, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Andriolo M, Pupier S, Jard S & Barberis C 1996 Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Letters 397 201-206.
11. Dohlman H, Thorner J, Caron M & Lefkowitz R 1991 Model systems for the study of seven-transmembrane-segment receptors. Annual Review of Biochemistry 60 653-688.
12. Freidinger RM & Pettibone DJ 1997 Small molecule ligands for oxytocin and vasopressin receptors. Medicinal Research Reviews 17 1-16.
13. Gopalakrishnan V, McNeill J, Sulakhe P & Triggle C 1988 Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethyl maleimide on agonist and antagonist interactions with the V1 subtype receptor. Endocrinology 123 922-931.
14. Grazzini E, Lodboerer AM, Perez-Martin A, Joubert D & Guillon G 1996 Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Endocrinology 137 3906-3914.
15. 8] vasotocin receptor. Proceedings of the National Academy of Sciences of the USA 93 6907-6912.
16. Howl J & Wheatley M 1996 Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors. Biochemical Journal 317 577-582.
17. Innamorati G, Sadeghi H & Bimbaumer MA 1996 Fully active nonglycosylated V2 vasopressin receptor. Molecular Pharmacology 50 467-473.
18. Jans D, Jans P, Luzius H & Fahrenholz F 1992 N-glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopressin V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression. Archives of Biochemistry and Biophysics 294 64-69.
19. Jard S, Elands J, Schmidt A & Barberis C 1988 Vasopressin and oxytocin receptors: an overview. In Progress in Endocrinology, pp 1183-1188. Eds H Imura & K Shizume. Amsterdam: Elsevier.
20. de Keyser Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna X & Clauser E 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Letters 356 215-220.
21. Kimura T, Tanizawa O, Mori K, Brownstein M & Okayama H 1992 Structure and expression of a human oxytocin receptor. Nature 356 526-529.
22. Kimura T, Makino Y, Saji F, Takemura M, Inoue T, Kikuchi T, Kubota Y, Azuma C, Nobunaga T, Tokugawa Y & Tanizawa O 1994 Molecular characterization of a cloned human oxytocin receptor. European Journal of Endocrinology 131 385-390.
23. Kojro E, Eich P, Gimpl G & Fahrenholz F 1993 Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. Biochemistry 32 13537-13544.
24. Liu J & Wess J 1996 Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. Journal of Biological Chemistry 271 8772-8778.
25. Lolait S, O'Carroll A, Mahan L, Felder C, Button D, Young III W, Mezey E & Brownstein M 1995 Extrapituitary expression of the rat V1b vasopressin receptor gene. Proceedings of the National Academy of Sciences of the USA 92 6783-6787.
26. Manning M & Sawyer W 1993 Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. Journal of Receptor Research 13 195-214.
27. Manning M, Cheng L, Stoev S, Sawyer WH, Tribollet E, Barberis C, Wo NC & Chan WY 1995 Novel potent and selective antagonists and radioiodinated ligands for oxytocin and vasopressin receptors. In Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research, pp 21-38. Eds T Saito, K Kurokawa & S Yoshida. Amsterdam: Elsevier.
28. Marc S, Leiber D & Harbon S 1986 Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea pig myometrium. FEBS Letters 201 9-14.
29. Mendre C, Dufour MN, Le Roux S, Seyer R, Guillou L, Calas B & Guillon G 1997 Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor. Journal of Biological Chemistry 272 21027-21036.
30. Michell RH, Kirk CJ & Billah MM 1979 Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochemical Society Transactions 7 861-865.
31. Mirronneau J 1976 Effects of oxytocin on ionic currents underlying rhythm activity and contraction in uterine smooth muscle. Pflüger's Archives 363 113-116.
32. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S & Barberis C 1995 The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. Journal of Biological Chemistry 270 25771-25777.
33. 341 in the carboxyl tail leads to an uncoupled non-palmitoylated form of the receptor. Journal of Biological Chemistry 264 7564-7569.
34. Orloff J & Handler J 1967 The role of adenosine 3′,5′-phosphate in the action of antidiuretic hormone. American Journal of Medicine 42 757-768.
35. Ovchinnikov YA, Abdulaev NG & Bogachuk AS 1988 Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsine are palmitoylated. FEBS Letters 230 1-5.
36. Pavo I & Fahrenholz F 1990 Differential inactivations of vasopressin receptor subtypes in isolated membranes and intact cells by N-ethylmaleimide. FEBS Letters 272 205-208.
37. Phalipou S, Cotte N, Carnazzi E, Seyer R, Jard S, Barberis C & Mouillac B 1997 Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist. Journal of Biological Chemistry 272 26536-26544.
38. Postina R, Kojro E & Fahrenholz F 1996 Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. Journal of Biological Chemistry 271 31593-31601.
39. Rosenthal W, Antaramian A, Gilbert S & Birnbaumer M 1993 Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. Journal of Biological Chemistry 268 13030-13033.
40. Sadeghi HM, Innamorati G & Birnbaumer M 1995 Functional properties of mutant V2 receptors. In Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research, pp 445-451. Eds T Saito, K Kurokawa & S Yoshida. Amsterdam: Elsevier.
41. Sadeghi HM, Innamorati G, Dagarag M & Birnbaumer M 1997 Palmitoylation of the V2 vasopressin receptor. Molecular Pharmacology 52 21-29.
42. Savarese T & Fraser C 1992 In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochemical Journal 283 1-19.
43. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S & Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. Journal of Biological Chemistry 269 27088-27092.
44. Tajima T, Nakae J. Takekoshi Y, Takahashi Y, Yuri K, Nagashima T & Fujieda K 1996 Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatric Research 39 522-526.
45. Thibonnier M, Goraya T & Berti-Mattera L 1993 G protein coupling of human platelet V1 vascular vasopressin receptors. American Journal of Physiology 264 C1336-C1344.
46. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L & Clauser E 1994 Molecular cloning sequencing and functional expression of a cDNA encoding the human V1a vasopressin receptor. Journal of Biological Chemistry 269 3304-3310.
47. Trumpp-Kallmeyer S, Chini B, Mouillac B, Barberis C, Hoflack J & Hibert M 1995 Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors. Pharmaceutica Acta Helvetiae 70 255-262.
48. Ufer E, Postina R, Gorbulev V & Fahrenholz F 1995 An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Letters 362 19-23.
49. Wess J 1996 Molecular biology of muscarinic acetylcholine receptors. Critical Reviews in Neurobiology 10 69-99.
50. Wess J, Nanavati S, Vogel Z & Maggio R 1993 Functional role of proline and tryptophan residues highly conserved among G protein-coupled rceptors studied by mutational analysis of the m3 muscarinic receptor. EMBO Journal 12 331-358.